Treatment of Kaposi sarcoma with vinblastine.
Five cases of Kaposi sarcoma with vinblastine sulfate treatment were compared with 18 cases reported in the literature. Our experience with a low-dosage schedule emphasizes that toxicity is not necessary for a favorable result. Vinblastine seems to be an effective treatment for Kaposi sarcoma and, in selected cases, may supplement radiation therapy or be used alone.
D000328:Adult; D000368:Aged; D004305:Dose-Response Relationship, Drug; D006801:Humans; D008207:Lymphatic Metastasis; D008297:Male; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy; D009378:Neoplasms, Multiple Primary / Q000188:drug therapy; D012514:Sarcoma, Kaposi / Q000188:drug therapy* / Q000532:radiotherapy; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy; D014747:Vinblastine / Q000009:adverse effects / Q000627:therapeutic use*
D014747:Vinblastine